BioSpace News Archive

Selected from school districts in communities where Northrop Grumman operates across the country, the Teacher Fellows will participate in a variety of science, technology, and engineering-related activities and professional learning opportunities.

Foghorn® Therapeutics Inc. (Foghorn), a company advancing an entirely new class of medicines targeting diseases with genetically determined dependencies in the chromatin regulatory system, today appointed Scott Biller, Ph.D., to its Board of Directors.

Can-Fite BioPharma Ltd. announced the agreement by several accredited investors to exercise certain warrants to purchase up to an aggregate of 22,278,540 ordinary shares represented by 742,618 American Depositary Shares having exercise prices ranging from $12.90 to $78.75 per ADS issued by Can-Fite in September 2015, October 2015, March 2018, January 2019 and April 2019, at a reduced exercise price of $3.25 per ADSs.

America’s Largest Independent Kidney Patient Organization Recognizes Top Professionals

NextGen Healthcare, Inc., a leading provider of ambulatory-focused technology solutions, will release its fiscal 2020 third quarter ended December 31, 2019 operating results on Thursday, January 23, 2020 after market close, with a conference call to follow at 5:00 p.m. Eastern Time.

FAST BioMedical announced the completion of the EMPAKT-CHF clinical trial at Charité – Universitätsmedizin Berlin and Kerckhoff Klinik in Bad Nauheim.

The Clarke Companies, a leading provider of packaging, automation, validation and vision inspection services to the Life Sciences Industry has added Covex, LLC, to its portfolio of businesses.

Retrotope announced that it has dosed its first patient in a Phase 2/3 clinical trial of RT001 in Friedreich’s ataxia, the most common of the inherited ataxias.

Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of agents that activate immune response to cancers, is pleased to announce the appointment of Dr. Jennifer Buell to President and COO.

Introducing SkinCeuticals SkinLab™: SkinCeuticals® Finds New Niche in ‘Approachable Aesthetics’